Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis K L Chan

Showing results (1-10 of 334) with videos related to

Pageof 34
Sort By:
Journal of Gastroenterology and Hepatology|December 7, 2011
Anti-platelet therapy and managing ulcer riskFrancis K L Chan
Evidence-Based Medicine|August 4, 2009
Rofecoxib increased risk of CV events in patients with history of colorectal adenomas > or = 1 year after stopping treatmentFrancis K L Chan
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 7, 2012
NSAID-associated lower gastrointestinal bleeding: where do we stand?Francis K L Chan
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2013
Endoscopic therapy as an alternative to radical surgery for early stage esophageal adenocarcinoma with submucosal invasion?Francis K L Chan
Lancet (London, England)|December 20, 2008
Proton-pump inhibitors in peptic ulcer diseaseFrancis K L Chan
Drug Safety|March 24, 2005
NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient managementFrancis K L Chan
Chinese Journal of Digestive Diseases|January 26, 2005
Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?Francis K L Chan
Current Pharmaceutical Design|October 8, 2003
COX-2 inhibition, H. pylori infection and the risk of gastrointestinal complicationsFrancis K L Chan
Nature Clinical Practice. Rheumatology|October 24, 2007
Proton-pump inhibitors as a protective treatment for high-risk patients receiving treatment with NSAIDsFrancis K L Chan
The American Journal of Gastroenterology|March 6, 2012
Editorial: single-tablet ibuprofen/double-dose famotidine for reduction of gastric and duodenal ulcers (REDUCE Trials): what can be reduced?Francis K L Chan
Pageof 34

Showing results (1-10 of 334) with videos related to

Sort By:
Pageof 34
Journal of Gastroenterology and Hepatology|December 7, 2011
Anti-platelet therapy and managing ulcer riskFrancis K L Chan
Evidence-Based Medicine|August 4, 2009
Rofecoxib increased risk of CV events in patients with history of colorectal adenomas > or = 1 year after stopping treatmentFrancis K L Chan
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 7, 2012
NSAID-associated lower gastrointestinal bleeding: where do we stand?Francis K L Chan
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2013
Endoscopic therapy as an alternative to radical surgery for early stage esophageal adenocarcinoma with submucosal invasion?Francis K L Chan
Lancet (London, England)|December 20, 2008
Proton-pump inhibitors in peptic ulcer diseaseFrancis K L Chan
Drug Safety|March 24, 2005
NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient managementFrancis K L Chan
Chinese Journal of Digestive Diseases|January 26, 2005
Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?Francis K L Chan
Current Pharmaceutical Design|October 8, 2003
COX-2 inhibition, H. pylori infection and the risk of gastrointestinal complicationsFrancis K L Chan
Nature Clinical Practice. Rheumatology|October 24, 2007
Proton-pump inhibitors as a protective treatment for high-risk patients receiving treatment with NSAIDsFrancis K L Chan
The American Journal of Gastroenterology|March 6, 2012
Editorial: single-tablet ibuprofen/double-dose famotidine for reduction of gastric and duodenal ulcers (REDUCE Trials): what can be reduced?Francis K L Chan
Pageof 34